title: [Hyperhidrosis is a silent handicap].
abstract: Hyperhidrosis affects 2.8% of the population and has severe negative influence on life quality. The disease is represented in many specialties but can unfortunately be incorrectly treated or not treated at all. Primary hyperhidrosis is the most common form. Secondary hyperhidrosis is most often excluded by a few anamnestic data. Botulinum toxin and anticholinergics are adequate treatment options when aluminium chloride is insufficient. This article describes the disease from the physician's as well as the patient's perspective. Furthermore, examination procedures and treatment procedures are presented.
authors: carl.swartling@svedklinikken.dk.
authors: Carl
authors: C
authors: Swartling
authors: Alma
authors: A
authors: Rystedt
authors: Kerstin
authors: K
authors: Brismar
authors: Hans
authors: H
authors: Naver
authors: Pontus
authors: P
authors: Norman
authors: Adis
authors: A
authors: Dizdarevic
mesh_terms: D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006945:Hyperhidrosis / Q000175:diagnosis / Q000209:etiology / Q000523:psychology / Q000628:therapy; D009498:Neurotoxins / Q000008:administration & dosage / Q000627:therapeutic use; D011788:Quality of Life; D013546:Sweating / Q000502:physiology
chemical_list: D018680:Cholinergic Antagonists; D009498:Neurotoxins; D019274:Botulinum Toxins, Type A